Safety
Peptide Side Effects Database
Evidence-based safety profiles for 20 peptides. Each page details common and rare adverse events with frequency data, contraindications, drug interactions, and special-population considerations — sourced from clinical trials, FDA labeling, and post-market surveillance.
Not medical advice. This information is compiled from published literature and regulatory documents for research and education. Always consult a qualified healthcare provider before starting any peptide.
AOD-9604
Lipolytic GH Fragment Activity
BPC-157
Angiogenesis & VEGF Modulation
CJC-1295
GHRH Receptor Agonism
Epithalon
Telomerase Activation
GHK-Cu
Copper-Dependent Gene Modulation
Ipamorelin
Ghrelin Receptor Agonism
Melanotan II
Non-Selective Melanocortin Agonism
MK-677
Oral Ghrelin Receptor Agonism
MOTS-c
Mitochondrial-Derived AMPK Activation
NAD+
Sirtuin & PARP Cofactor
PT-141
Melanocortin MC4R Agonism
Retatrutide
Triple GIP/GLP-1/Glucagon Agonism
Selank
Tuftsin Analog / Immune-Neuro Modulation
Semaglutide
GLP-1 Receptor Agonism
Semax
Melanocortin & BDNF Signaling
Sermorelin
GHRH Receptor Agonism
TB-500
Actin Sequestration & Cell Migration
Tesamorelin
GHRH Receptor Agonism
Thymosin Alpha-1
Dendritic Cell & T-Cell Activation
Tirzepatide
Dual GIP/GLP-1 Agonism